CLINICAL_TRIALS
research
· 2026-01-28
Clinical Trial Update: Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance [NA]
Summary
A clinical trial is recruiting to evaluate the effects of Sabroxy supplementation on insulin resistance and cognitive function in adults with mild cognitive imp…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: SF Research Institute, Inc. | Conditions: Insulin Resistance, Mild Cognitive Impairment | NA | Status: RECRUITING